Drug intelligence / Profile preview

EXOSTEO01

Development stage
Preclinical
Lead developer
ConvEyXO
Modality
Cell Therapies, RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01

Overview

EXOSTEO01 is an investigational, RNA-enhanced exosome therapeutic under development by ConvEyXO for the treatment of osteoarthritis. The therapy is designed to address the root causes of degenerative joint disease by reducing inflammation, restoring cellular balance, and promoting tissue repair. EXOSTEO01 utilizes exosomes derived from an immortalized, single-donor Wharton's-jelly mesenchymal stem cell line. These exosomes are loaded with therapeutic RNA or miRNA cargo using ConvEyXO's patented microfluidic-based mechanoporation technology, which temporarily increases mechanical porosity to allow payload absorption without compromising the natural therapeutic properties of the vesicles. EXOSTEO01 is currently in preclinical development.

Other names
RNA-enhanced exosomes

Beyond the preview

Go deeper on EXOSTEO01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EXOSTEO01.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call